Abstract
Objective
To assess the effect of monotherapy with Carbamazepine (CBZ) and Sodium valproate (VPA) on serum 25-OH vitamin D levels in children with epilepsy compared to controls.
Design
Cross-sectional study.
Setting
Outpatient department of a tertiary-care Pediatric Neurology centre, and a nearby day-care centre and school.
Study period
June 2012 to May 2013
Participants
Children with epilepsy aged 2 to 13 years on monotherapy with CBZ (n=28) or VPA (n=28) for at least 6 months; 109 age-matched controls from a nearby day-care centre and school.
Results
The median (IQR) values of 25 (OH) vitamin D was 18.0 ng/mL (13.7-27.3), 21.35 ng/mL (16.4 -25.2) and 30.5 ng/mL (19.1-43.7) in CBZ, VPA and control group, respectively (P=0.008). 60.7% of patients in CBZ group and 35.7 % in VPA group had low 25 (OH) D levels (<20 ng/mL) compared to 27.8% in controls (P=0.001).The serum alkaline phosphatase level was higher in children on carbamazepine therapy (P=0.001) than controls.
Conclusion
This study identifies significant risk of vitamin D deficiency in ambulant children with epilepsy on monotherapy with CBZ or VPA.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Offermann G, Pinto V, Kruse R. Antiepileptic drugs and vitamin D supplementation. Epilepsia. 1979; 20:3–15.
Fong CY, Mallick AA, Buren CP, Patel JS. Evaluation and management of bone health in children with epilepsy on long-term antiepileptic drugs: United Kingdom survey of paediatric neurologists. Eur J Paediatr Neurol. 2011; 15:417–23.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al; Endocrine Society. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. Horm Res Paediatr. 2016; 85:83–106.
Ramelli V, Ramelli GP, Lava SA, Siegenthaler GM, Cantù M, Bianchetti MG, et al. Vitamin D status among children and adolescents on anticonvulsant drugs in Southern Switzerland. Swiss Med Wkly. 2014; 13:w13996.
Coppola G, Fortunato D, Auricchio G, Mainolfi C, Operto FF, Pascotto A, et al. Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia. 2009;50:2140–6.
Borusiak P, Langer T, Heruth M, Karenfort M, Bettendorf U, Jenke AC. Antiepileptic drugs and bone metabolism in children: Data from 128 patients. J Child Neurol. 2013;28:176–83.
Lee YJ, Park KM, Kim YM, Yeon GM, Nam SO. Longitudinal change of vitamin D status in children with epilepsy on antiepileptic drugs: prevalence and risk factors. Pediatr Neurol. 2015;52:153–9.
Fong CY, Kong AN, Poh BK, Mohamed AR, Khoo TB, Ng RL, et al. Vitamin D deficiency and its risk factors in Malaysian children with epilepsy. Epilepsia. 2016;57:1271–9.
Seth A, Aneja S, Singh R, Majumdar R, Sharma N, Gopinath M. Effect of impaired ambulation and antiepileptic drug intake on vitamin D status of children with cerebral palsy. Paediatr Int Child Health. 2017;37:193–8.
Misra A, Aggarwal A, Singh O, Sharma S. Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children. Pediatr Neurol. 2010; 43:320–4.
Menon B, Harinarayan CV. The effect of anti-epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism–A longitudinal study. Seizure. 2010;19:153–8.
Turan MI, Cayir A, Ozden O, Tan H. An examination of the mutual effects of valproic acid, carbamazepine, and phenobarbital on 25-hydroxyvitamin D levels and thyroid function tests. Neuropediatrics. 2014;45:16–21.
Rauchenzauner M, Griesmacher A, Tatarczyk T, Haberlandt E, Strasak A, Zimmerhackl LB, et al. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Dev Med Child Neurol. 2010;52:283–8.
Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs. 2001;15:633–42.
Tomita S, Ohnishi J, Nakano M, Ichikawa Y. The effects of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase systems. J Steroid Biochem Mol Biol. 1991;39:479–85.
Uitterlinden AG, Fang Y, Bergink AP, van Meurs JB, van Leeuwen HP, Pols HA. The role of vitamin D receptor gene polymorphisms in bone biology. Mol Cell Endocrinol. 2002;197:15–21.
Coppola G, Fortunato D, Auricchio G, Mainolfi C, Operto FF, Pascotto A, et al. Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia. 2009;50:2140–6.
Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan Gel-H. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone. Neurology. 2006;67:2005–11.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sreedharan, M., Devadathan, K., Kunju, P.A.M. et al. Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy. Indian Pediatr 55, 307–310 (2018). https://doi.org/10.1007/s13312-018-1273-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-018-1273-9